Author

A. Zarubica

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 3 Bioengineering· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:mouse· 4 Approach:experimental assay· 3 Research Focus:host-pathogen & immune response· 3 Research Focus:benchmarking· 1 Research Focus:cell type annotation· 1 Research Focus:clustering· 1 Approach:deep learning· 1 Research Focus:differential expression· 1

Frequent Co-Authors

B. Malissen· 3 shared M. Fabregue· 2 shared S. Sharkaoui· 2 shared A. Sansoni· 1 shared A. Wiedemann· 1 shared C. Degos· 1 shared C. Demerle· 1 shared C. Dong· 1 shared

Activity by Year

2021-2023 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersImmunology

B. Malissen

Mutual co-authors in cluster

Author profile →

4 papers

Recent·Most cited

BioengineeringbioRxivPreprintApr 3, 2023

nanoCLAMP potently neutralizes SARS-CoV-2 and protects K18-hACE2 mice from infection

Q. Pagneux, N. Garnier, M. Fabregue…·S. Szunerits

This paper develops a multi-epitope nanoCLAMP that neutralizes SARS-CoV-2 variants and protects mice from infection.

DOI 10.1101/2023.04.03.535401

mouseexperimental assay

𝕏 PostBluesky

ImmunologybioRxivPreprintNov 4, 2022

Anti-HVEM mAb therapy improves antitumoral immunity both in vitro and in vivo, in a novel transgenic mouse model expressing human HVEM and BTLA molecules challenged with HVEM expressing tumors

C. Demerle, L. Gorvel, M. Mello…·D. Olive

DOI 10.1101/2022.11.04.515180

mouseproteomics

𝕏 PostBluesky

ImmunologybioRxivDec 28, 2021

Design, immunogenicity, and efficacy of a pan-sarbecovirus dendritic-cell targeting vaccine

S. Coleon, A. Wiedemann, M. Surenaud…·Y. Levy

This study designs a pan-sarbecovirus vaccine targeting conserved epitopes and shows it induces cross-neutralizing antibodies and T-cell responses in mice and humans.

DOI 10.1016/j.ebiom.2022.104062

mouseexperimental assay

𝕏 PostBluesky

ImmunologybioRxivPreprintDec 14, 2021

Viral infection engenders bona fide and bystander lung memory B cell subsets through permissive selection

C. Gregoire, L. Spinelli, S. Villazala-Merino…·M. Gaya

The paper identifies two distinct lung memory B cell subsets post-viral infection, showing they arise from different progenitors and are classified as virus-specific or bystander based on antigen specificity.

DOI 10.1101/2021.12.14.472614

𝕏 PostBluesky